Delivery Order SPE2DB22D1041-SPE2DB24FUBU8

Award Date 5/31/24
Potential Completion Date 6/3/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $16,865.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order to provide UBRELVY 100 MG TABLET UD 16S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,063.73 delivery order contract is for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2024 and is a Firm Fixed Price instrument. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product UBRELVY 50 MG TABLET UD 10S. The $1,108.32 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on July 11, 2024, with a completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,265.71 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of UBRELVY 100 MG TABLET UD 16S. The $25,764.37 firm fixed-price delivery order has a completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,884.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a medication, with a completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,148.46 firm fixed-price delivery order is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,898.48 firm-fixed-price delivery order is for the provision of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,634.72, is a delivery order contract for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,334.66 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 16S medical products. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUBU8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of UBRELVY 100 MG TABLET UD 16S medication. The contract, valued at $2,061.44, is a firm fixed price delivery order that runs through June 3, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. As a major supplier to the federal government, Amerisourcebergen's expertise in pharmaceutical distribution allows it to efficiently manage the complex logistics of supplying critical medical products to government facilities.

Generated 8/30/24, 6:33 PM